Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 410 participants.
Also called NCT07698223
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 410 participants
- Sponsor
- Chen Xiangmei
- Registry
-
NCT07698223
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07698223. Randomized; double masking; primary purpose treatment. Start 2027-03-01 (anticipated); primary completion 2028-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD
- Acronym
- NXT-DKD
- Condition
- Diabetic Nephropathy
- Intervention (Drug)
- Naoxintong Capsule
- Intervention (Drug)
- Placebo
- Lead sponsor
- Chen Xiangmei
Record details
- Record id
cardio:ct-nct07698223- Content hash
6949eb6533f27ab275a9337bab7774a5decacb3ceb16cc5a37798b9d894d32ef